Skip to content
inentertainment.co.uk
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Allogene Therapeutics, Inc.
Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Solid Tumors
July 15, 2026
Allogene Therapeutics Announces Planned CEO Succession
May 28, 2026
Allogene Therapeutics Announces Participation in Upcoming Investor Conferences
May 26, 2026
Allogene Therapeutics Reports First Quarter 2026 Financial Results and Business Update
May 24, 2026
←
Previous Page
1
2